101 results
Page 3 of 6
8-K
EX-99.1
g7i06urxbejtn2o
12 Apr 21
Sage Therapeutics and Biogen Announce SAGE-324 Phase 2 Placebo-Controlled KINETIC Study in Essential Tremor Met Primary Endpoint
7:17am
8-K
EX-99.1
00e90vfx
24 Feb 21
Sage Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Highlights Pipeline and Business Progress
6:46am
8-K
EX-99.1
m1phj
5 Nov 20
Sage Therapeutics Announces Third Quarter 2020 Financial Results and Highlights Pipeline and Business Progress
7:00am
CORRESP
agam zo4oqvuofw
20 Aug 20
Correspondence with SEC
12:00am
8-K
EX-99.1
0w1qtr8
10 Aug 20
Sage Therapeutics Announces Second Quarter 2020 Financial Results and Highlights Pipeline and Business Progress
7:00am
UPLOAD
vpgd uez6uxftqu9zw6
23 Jul 20
Letter from SEC
12:00am
8-K
EX-99.1
vs38buf 53wnrao
7 May 20
Sage Therapeutics Announces First Quarter 2020 Financial Results and Highlights Pipeline and Business Progress
4:27pm
8-K
EX-99.1
a455je l9eg1a4qa
27 Feb 20
Sage Therapeutics Announces Fourth Quarter and Full Year 2019 Financial Results and Highlights Pipeline and Business Progress
6:45am
8-K
EX-99.1
g7er9qhfp8c ecapb
5 Dec 19
Sage Therapeutics Reports Topline Results from Pivotal Phase 3
7:01am
8-K
EX-99.1
d9ric od2
12 Nov 19
Sage Therapeutics Announces Third Quarter 2019 Financial Results and Highlights
6:44am